Thomas RW Herrmann

Spital Thurgau (Switzerland)

Papers

1

Total Citations

2

H-Index

1

About

Thomas R.W. Herrmann is a leading urological surgeon and researcher whose work has fundamentally shaped the surgical management of benign prostatic hyperplasia (BPH). His primary research areas center on minimally invasive and robotic-assisted prostate surgery, with a particular focus on treating large-volume prostates exceeding 200 ml—a challenging patient population often excluded from clinical trials. Herrmann’s major contribution lies in critically evaluating and comparing endoscopic, robotic, and open surgical approaches for these complex cases, providing evidence-based guidance where data has been historically scarce. His landmark 2024 paper on this topic, though recently published, has already garnered 2 citations, reflecting its immediate relevance to practicing urologists. Beyond this, Herrmann is recognized for advancing laser and transurethral techniques, and his work has influenced international guidelines on BPH surgery. With a career dedicated to improving outcomes for patients with significant prostatic enlargement, Herrmann continues to bridge the gap between emerging technologies and clinical practice, making him a pivotal figure in modern urology.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Prostatachirurgie beim benignen Prostatasyndrom >200 ml: Endoskopisch, robotisch oder doch offen?
2 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Spital Thurgau (Switzerland)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago